A detailed history of Emprise Bank transactions in Eli Lilly & CO stock. As of the latest transaction made, Emprise Bank holds 604 shares of LLY stock, worth $463,727. This represents 0.31% of its overall portfolio holdings.

Number of Shares
604
Previous 1,060 43.02%
Holding current value
$463,727
Previous $960 Million 44.24%
% of portfolio
0.31%
Previous 0.59%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 01, 2024

SELL
$772.14 - $960.02 $352,095 - $437,769
-456 Reduced 43.02%
604 $535 Million
Q2 2024

Jul 29, 2024

SELL
$724.87 - $909.04 $17,396 - $21,816
-24 Reduced 2.21%
1,060 $960 Million
Q1 2024

Apr 08, 2024

BUY
$592.2 - $792.28 $641,944 - $858,831
1,084 New
1,084 $843 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Emprise Bank Portfolio

Follow Emprise Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emprise Bank, based on Form 13F filings with the SEC.

News

Stay updated on Emprise Bank with notifications on news.